Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Roche presents Toll-like receptor 8 agonists

April 5, 2017

Roche and collaborators patent anti-influenza compounds

April 4, 2017

INSERM and collaborators divulge novel GPBAR1 agonists

April 4, 2017

Taiho Pharmaceutical discovers new proto-oncogene RET inhibitors

April 4, 2017

GlaxoSmithKline identifies novel PERK inhibitors

April 4, 2017

Janssen, Katholieke Universiteit Leuven patent dengue virus replication inhibitors

April 3, 2017

Redx Pharma identifies novel antibacterial compounds

April 3, 2017

Novel cyclin-dependent kinase inhibitors discovered at Dana-Farber Cancer Institute

April 3, 2017

Assembly Biosciences and partner disclose hepatitis B core protein modulators

March 31, 2017

Dana-Farber Cancer Institute presents BRD4 and BRDT inhibitors

March 31, 2017

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...